C. Alm

University of Toronto — Canada

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

14h-index1.1kcitations19works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(8), Cancer Treatment and Pharmacology(4), Anesthesia and Pain Management(2), Anesthesia and Sedative Agents(2), Pharmacology and Obesity Treatment(2)

Publications19 total

Maternal perinatal diet induces developmental programming of bone architecture
Journal of Endocrinology·2013· 29 citedOpen Access
Insights into the search for new drugs from traditional knowledge: An ethnobotanical and chemical–ecological perspective
Pharmaceutical Biology·2011· 22 citedOpen Access
Comparative in vitro and in vivo study of a sugar-coated chloroquine preparation marketed in Tanzania versus an ordinary brand
Journal of Clinical Pharmacy and Therapeutics·2008· 1 cited
178 Association Between Expression of HLA-A2 and Ovarian Cancer
International Journal of Gynecological Cancer·2004
Comparative in vitro and in vivo study of a sugar-coated chloroquine preparation marketed in Tanzania versus an ordinary brand
Journal of Clinical Pharmacy and Therapeutics·2001· 33 cited
Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype.
PubMed·1999· 75 cited
Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast‐dissolving tablets to fasting healthy volunteers
Alimentary Pharmacology & Therapeutics·1997· 31 citedOpen Access
Quantification of the O- and N-Demethylated and the Glucuronidated Metabolites of Codeine Relative to the Debrisoquine Metabolic Ratio in Urine in Ultrarapid, Rapid, and Poor Debrisoquine Hydroxylators
Therapeutic Drug Monitoring·1997· 44 cited
Intraindividual and Interindividual Variability in the Disposition of the Local Anesthetic Ropivacaine in Healthy Subjects
Therapeutic Drug Monitoring·1997· 43 cited
In Vitro and In Vivo Studies on the Disposition of Mirtazapine in Humans
Clinical Drug Investigation·1997· 78 cited
Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans
British Journal of Clinical Pharmacology·1996· 15 citedOpen Access
Pharmacokinetics - Absorption and Disposition - of Ropivacaine after Epidural Administration using Isotope Technique.
Regional Anesthesia The Journal of Neural Blockade in Obstetrics Surgery & Pain Control·1995Open Access
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.
British Journal of Clinical Pharmacology·1994· 306 citedOpen Access
Polymorphic 2-hydroxylation of desipramine
European Journal of Clinical Pharmacology·1993· 29 cited
Lack of relationship between glibenclamide metabolism and debrisoquine or mephenytoin hydroxylation phenotypes.
British Journal of Clinical Pharmacology·1990· 12 citedOpen Access
The role of locally situated opioid receptors in the inhibitory effect of codeine on gastrointestinal transit in man
Pain·1990
Codeine O‐demethylation co‐segregates with polymorphic debrisoquine hydroxylation.
British Journal of Clinical Pharmacology·1989· 135 citedOpen Access
Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.
British Journal of Clinical Pharmacology·1989· 116 citedOpen Access
DEBRISOQUINE HYDROXYLATION POLYMORPHISM AND PERSONALITY
The Lancet·1989· 120 cited

Frequent Co-authors

Leif Bertilsson(5), Lars L. Gustafsson(5), Juliette Säwe(4), Amos Massele(3), Y. Aden-Abdi(3), Q-Y Yue(2), JO Svensson(2), Folke Sjöqvist(2), Marja­‐Liisa Dahl(2), Inger Johansson(2), Magnus Ingelman‐Sundberg(2), Jan Olof Svensson(2), Stephen E. D. Nsimba(2), G. Rimoy(2), Örjan Ericsson(2), JA Carrillo(1), M-L Dahl(1), Adrián LLerena(1), Ulf Bondesson(1), L. Lindström(1)